|
nasdaq:exel
|
8013
|
Apr 21st, 2024 12:00AM
|
Exelixis
|
48K
|
1504
|
Open
|
|
Apr 20th, 2024 11:25PM
|
Apr 20th, 2024 11:25PM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 20th, 2024 12:00AM
|
Exelixis
|
48K
|
1504
|
Open
|
|
Apr 19th, 2024 11:22PM
|
Apr 20th, 2024 04:57PM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 19th, 2024 12:00AM
|
Exelixis
|
48K
|
1503
|
Open
|
|
Apr 18th, 2024 11:29PM
|
Apr 18th, 2024 11:29PM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 18th, 2024 12:00AM
|
Exelixis
|
48K
|
1503
|
Open
|
|
Apr 17th, 2024 11:37PM
|
Apr 18th, 2024 06:18PM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 17th, 2024 12:00AM
|
Exelixis
|
48K
|
1504
|
Open
|
|
Apr 16th, 2024 11:19PM
|
Apr 17th, 2024 02:42PM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 16th, 2024 12:00AM
|
Exelixis
|
48K
|
1504
|
Open
|
|
Apr 15th, 2024 11:16PM
|
Apr 16th, 2024 10:59AM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 15th, 2024 12:00AM
|
Exelixis
|
48K
|
1504
|
Open
|
|
Apr 14th, 2024 11:11PM
|
Apr 15th, 2024 04:40PM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 14th, 2024 12:00AM
|
Exelixis
|
48K
|
1510
|
Open
|
|
Apr 13th, 2024 11:00PM
|
Apr 14th, 2024 10:58AM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 13th, 2024 12:00AM
|
Exelixis
|
48K
|
1511
|
Open
|
|
Apr 12th, 2024 10:51PM
|
Apr 13th, 2024 11:26AM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:exel
|
8013
|
Apr 12th, 2024 12:00AM
|
Exelixis
|
48K
|
1511
|
Open
|
|
Apr 11th, 2024 10:56PM
|
Apr 12th, 2024 08:21AM
|
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
|
Open
|
|
Open
|
1851 Harbor Bay Pkwy
|
Alameda
|
California
|
US
|
94502
|
|
Exelixis
|
Health Care
|
Pharmaceuticals & Biotechnology
|